The Deal
Sunday, November 22, 
11:49 pm

Safeguard Scientifics gets funding

  Share     E-Mail    Discussion    Print Story
Published July 10, 2007 at 5:22 PM

Who says incubators are dead? Long-time surviving incubator Safeguard Scientifics Inc., technically a holding company that builds technology and life sciences startups, said Tuesday that one of its companies, Pittsburgh-based Cellumen Inc., has raised $8.7 million in Series B funding, American Venture Magazine and the Pittsburgh Business Times reported. Safeguard provided $6 million of the financing for Cellumen, a cellular systems biology company. The other investor included PA Early Stage Partners, which contributed $2 million. PA Early Stage Partners had also invested in the company's Series A round. Cellumen plans to use the funds to build out its management team and to develop and commercialize its cellular models of disease and cytotoxicity profiling services and products. —Stacey Higginbotham

See July 10 story from AmericanVentureMagazine.com
See July 10 story from the Pittsburgh Business Times
See June 21, 2005, brief from TheDeal.com

Continue reading below

Also on Dealscape





Post a comment




The Deal Pipeline

Deal Video


Inside The Deal: Avaya Inc.'s Mohamad Ali on the company's next target.

More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

Managing your shareholder base

By Bradford P. Weirick and Joelle Khoury, Gibson Dunn

Growth companies and their PE sponsors should be wary of the pitfalls that arise when they layer on tiers of preferred stock.


Industry Insight

Easing the stress of distressed M&A

By Derek Watson, KPMG

Corporate buyers face numerous complexities when trying to identify the right moment to purchase a distressed asset.


Editor's Note

Editor's letter: Nov. 16, 2009

By Robert Teitelman

Beneath the veneer of Wall Streeters beats the same heart, stirred by the same determinants of behavior.



©Copyright 2008, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.